Skip to main content
Premium Trial:

Request an Annual Quote

Genomenon, Veritas Partner to Apply AI to Next Generation of Variant Classification

NEW YORK (GenomeWeb) – DNA sequencing company Veritas Genetics is partnering with genomic literature search engine Genomenon in an effort to move literature prioritization forward with the help of artificial intelligence.

The two companies said today that they would apply genomic language processing, machine learning, and AI to develop a new literature prioritization engine, following established variant classification schemes. Toward this goal, Veritas will integrate Genomenon's Mastermind analytic and data visualization tool into its own genome interpretation technology and advise Genomenon on enhancements to Mastermind.

In announcing the partnership, Ann Arbor, Michigan-based Genomenon called WGS interpretation the "single most critical hurdle to realize the promise of genomic medicine." Through this deal, the companies hope to drive down the cost and improve accuracy of variant classification while simplifying updates to classifications as the science advances.  

"Variant classification sits at the center of the genomic revolution," Genomenon CEO Mike Klein said in a statement. "We look forward to radically moving the field forward through our collective expertise and variant interpretation tools."

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.